Boehringer Ingelheim calls for 2018 Equine Research Awards proposalsAugust 6, 2018Boehringer Ingelheim is accepting proposals for the 2018 Advancement in Equine Research Awards for Equine Respiratory Disease Research. Veterinarians, diagnosticians, and public and private researchers in the U.S., Canada, and Mexico are eligible to submit proposals for research programs that help advance the diagnosis, treatment, and understanding of equine disease. Boehringer Ingelheim will present five separate $15,000 awards focused on two specific disease topics. Proposals must address either equine infectious respiratory disease or equine …
SPONSORED CONTENTA new way to offer multi-organ supportNEW Hill's Prescription Diet Multi-Organ offers therapeutic nutrition for pets that may have conflicting nutritional needs. + Learn More
Heartgard producer announces heartworm awareness campaignApril 16, 2018 Merial, now a part of Boehringer Ingelheim (BI), announced a multifaceted campaign to assist veterinarians and clinic teams in promoting the consistent use of heartworm preventive medications for their patients. The announcement follows a recent survey conducted by the company, which showed a decreased use of year-round heartworm preventive measures and a corresponding increase in instances of the disease. "After years of steady progress in reducing the numbers of heartworm-positive …
Experts discuss lone star tick population, associated diseaseMarch 2, 2018Three health professionals in human allergy, parasitology, and entomology brought new perspectives on the lone star tick issue during a panel discussion sponsored by Boehringer Ingelheim at VMX: Veterinary Meeting & Expo 2018 in Orlando, Fla. Onyinye Iweala, MD, Ph.D., allergist and immunologist at the University of North Carolina-Chapel Hill; Brian Herrin, DVM, Ph.D., DACVM, assistant professor at Kansas State University College of Veterinary Medicine; and Thomas Mather, Ph.D., professor of …
Boehringer Ingelheim, Merial launch Recombitek Oral BordetellaFebruary 14, 2018Merial, now part of Boehringer Ingelheim, has launched Recombitek Oral Bordetella, an oral vaccine shown to be effective against canine infectious tracheobronchitis caused by Bordetella bronchiseptica, the company reported. Clinical studies suggest that as a mucosal vaccine, it offers dogs a robust immune response after a single dose, according to the manufacturer. B. bronchiseptica, one of the primary pathogens responsible for canine infectious respiratory disease complex, is unique in its ability …
Boehringer Ingelheim panel to discuss lone star ticks at Florida vet conferenceJanuary 31, 2018At 2018 VMX: Veterinary Meeting & Expo in Orlando, Fla., Boehringer Ingelheim will host a panel discussion on the diseases transmitted by the lone star tick affecting dogs and humans, "Lone Star Tick: Risk to Dogs, Risk to Humans." According to the Centers for Disease Control and Prevention, lone star ticks are found in at least 30 U.S. states, and are they are spreading to new areas of the country. …
Boehringer Ingelheim announces $80M expansion investmentDecember 5, 2017Boehringer Ingelheim announced it will invest more than $80 million to expand its existing facilities in Athens, Ga., and St. Joseph, Mo., to accommodate increased production of animal vaccines. The company's facility in Athens, Ga., will grow from its current footprint of approximately 350,000 square feet to 400,000 square feet, and will nearly double its filling capacity for companion animal and avian vaccines. Construction is slated to begin in the …
Boehringer Ingelheim funds three equine research awardsNovember 22, 2017Boehringer Ingelheim has selected three research proposals to fund as part of its 2017 Advancement in Equine Research Award program. The company has given more than $470,000 to advancing the knowledge of equine infectious disease since 2011. "For the past six years, BI has supported equine research into identifying new disease treatment and prevention methods," said Steve Grubbs, DVM, Ph.D., DACVIM, equine technical manager at Boehringer Ingelheim. "Through this program we …
Boehringer Ingelheim unveils new equine brand platformAugust 31, 2017Boehringer Ingelheim is introducing a new brand platform: Unbridle Your Potential—health care products to help unlock the potential in each horse.
Researchers step up fight against parasitesMay 20, 2016Pharmaceutical giant Boehringer Ingelheim Animal Health is teaming up with a Scottish university and another European institution to find better treatments for parasitic diseases.
